879460-37-4Relevant articles and documents
Lead optimization of spiropyrazolopyridones: A new and potent class of dengue virus inhibitors
Zou, Bin,Chan, Wai Ling,Ding, Mei,Leong, Seh Yong,Nilar, Shahul,Seah, Peck Gee,Liu, Wei,Karuna, Ratna,Blasco, Francesca,Yip, Andy,Chao, Alex,Susila, Agatha,Dong, Hongping,Wang, Qing Yin,Xu, Hao Ying,Chan, Katherine,Wan, Kah Fei,Gu, Feng,Diagana, Thierry T.,Wagner, Trixie,Dix, Ina,Shi, Pei-Yong,Smith, Paul W.
, p. 344 - 348 (2015)
Spiropyrazolopyridone 1 was identified, as a novel dengue virus (DENV) inhibitor, from a DENV serotype 2 (DENV-2) high-throughput phenotypic screen. As a general trend within this chemical class, chiral resolution of the racemate revealed that R enantiomer was significantly more potent than the S. Cell-based lead optimization of the spiropyrazolopyridones focusing on improving the physicochemical properties is described. As a result, an optimal compound 14a, with balanced in vitro potency and pharmacokinetic profile, achieved about 1.9 log viremia reduction at 3 × 50 mg/kg (bid) or 3 × 100 mg/kg (QD) oral doses in the dengue in vivo mouse efficacy model.